UConn professors Lakshmi Nair, Ph.D. and Yusuf Khan, Ph.D., in the Department of Orthopedic Surgery, believe they are on the cusp of a breakthrough pain-reduction treatment that is both highly effective and safe. Nair has been working to significantly extend the duration of local anesthetics, enabling patients to be pain-free, mobile, and benefit from medications that have been safely used for decades. The pain medication would be delivered by injection.
Their pharmaceutical company, Soleia Biosciences, has been identified as one of five extremely promising UConn-affiliated startups. They will be pitching in the Wolff New Venture Competition on Oct. 1 in Downtown Hartford.